Literature DB >> 21268780

New developments in CSF biomarkers for early detection and monitoring of Parkinson disease.

Darran Yates.   

Abstract

Entities:  

Year:  2011        PMID： 21268780     DOI： 10.1038/nrneurol.2010.184

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  2 in total

1.  Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease.

Authors:  T Tokuda; M M Qureshi; M T Ardah; S Varghese; S A S Shehab; T Kasai; N Ishigami; A Tamaoka; M Nakagawa; O M A El-Agnaf
Journal:  Neurology       Date:  2010-10-20       Impact factor: 9.910

2.  Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression.

Authors:  Min Shi; Joshua Bradner; Aneeka M Hancock; Kathryn A Chung; Joseph F Quinn; Elaine R Peskind; Douglas Galasko; Joseph Jankovic; Cyrus P Zabetian; Hojoong M Kim; James B Leverenz; Thomas J Montine; Carmen Ginghina; Un Jung Kang; Kevin C Cain; Yu Wang; Jan Aasly; David Goldstein; Jing Zhang
Journal:  Ann Neurol       Date:  2011-03-11       Impact factor: 10.422
  2 in total
  1 in total

Review 1.  Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment.

Authors:  Luis F Gonzalez-Cuyar; Joshua A Sonnen; Kathleen S Montine; C Dirk Keene; Thomas J Montine
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.